Advent Venture Partners

Advent Venture Partners is a venture capital and private equity firm specializing in startups, seed, early, mid-stage, late venture, emerging growth investments, later stage, buyout, and growth capital investments.

Advent Venture Partners is a firm investing in tech and life sciences businesses. It is based in London and was founded in 1981.

Advent Venture Partners is a privately held venture capital & private equity company. It operates in the following areas: venture capital, growth capital, technology, digital media, e-commerce, internet, mobile, software, cleantech, consumer, life sciences, biotech, biopharma, medical devices, platform technologies, and financing.

The firm prefers to invest in innovative life sciences, telecommunication services, utilities, and information technology sectors. In innovative life sciences, it prefers to invest in diagnostics, biopharmaceuticals, medical device research and development, pharmaceuticals, platform technologies, and companies seeking to develop breakthrough products for unmet medical needs with a special focus on new drug discovery- small molecules, biologics and new modalities including med tech, enabling technologies and vaccines. In information technology, the firm focuses on communications, clean technology, digital media & Internet, e-commerce, semiconductor & components, and software & services.

Advent Venture Partners has made 78 investments as of February 2019.It has had 27 exits. The most notable exits include Farfetch, WorldStores, and Dailymotion.

Advent Venture Partners has raised a total of $492.6M across 3 funds. The Advent Life Sciences Fund II LP was announced on Sep 10, 2014, and raised a total of $146.3M.

It focuses on investments in the United Kingdom, Western European, Europe, and the United States. Within Western European markets, it prefers to invest in Andorra, Portugal, and Spain. Within Utilities, it prefers to invest in Alternate energy Resources, Independent power producers, and energy traders.

The firm typically invests between £5 million ($9.46 million) and £15 million ($29 million) in its portfolio companies. Its technology investments focus on startups with sales above €4 million ($5.7 million) and which are often seeking external capital for the first time. For information technology investments, the firm prefers to take small minority positions to full buyouts and a majority stake in a portfolio company. It seeks to take a board seat in its portfolio companies.